Trial · NCT01134614
Adverse events248
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 248
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Arm A (Ipilimumab and Sargramostim) | 22 | 118 | |
| other | Anemia | Blood and lymphatic system disorders | Arm B (Ipilimumab) | 24 | 120 | |
| other | Chills | General disorders | Arm A (Ipilimumab and Sargramostim) | 18 | 118 | |
| other | Chills | General disorders | Arm B (Ipilimumab) | 8 | 120 | |
| other | Edema limbs | General disorders | Arm A (Ipilimumab and Sargramostim) | 10 | 118 | |
| other | Edema limbs | General disorders | Arm B (Ipilimumab) | 4 | 120 | |
| other | Fatigue | General disorders | Arm A (Ipilimumab and Sargramostim) | 70 | 118 | |
| other | Fatigue | General disorders | Arm B (Ipilimumab) | 75 | 120 | |
| other | Fever | General disorders | Arm A (Ipilimumab and Sargramostim) | 17 | 118 | |
| other | Fever | General disorders | Arm B (Ipilimumab) | 18 | 120 | |
| other | Injection site reaction | General disorders | Arm A (Ipilimumab and Sargramostim) | 62 | 118 | |
| other | Injection site reaction | General disorders | Arm B (Ipilimumab) | 0 | 120 | |
| other | Pruritus | Skin and subcutaneous tissue disorders | Arm A (Ipilimumab and Sargramostim) | 50 | 118 | |
| other | Pruritus | Skin and subcutaneous tissue disorders | Arm B (Ipilimumab) | 54 | 120 | |
| other | Rash maculo-papular | Skin and subcutaneous tissue disorders | Arm A (Ipilimumab and Sargramostim) | 62 | 118 | |
| other | Rash maculo-papular | Skin and subcutaneous tissue disorders | Arm B (Ipilimumab) | 57 | 120 | |
| other | Skin and subcutaneous tissue - Other | Skin and subcutaneous tissue disorders | Arm A (Ipilimumab and Sargramostim) | 7 | 118 | |
| other | Skin and subcutaneous tissue - Other | Skin and subcutaneous tissue disorders | Arm B (Ipilimumab) | 1 | 120 | |
| other | Adrenal insufficiency | Endocrine disorders | Arm A (Ipilimumab and Sargramostim) | 7 | 118 | |
| other | Adrenal insufficiency | Endocrine disorders | Arm B (Ipilimumab) | 2 | 120 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01134614/events